Cargando…
Frontiers in the COVID-19 vaccines development
Novel corona virus caused pneumonia first reported in December, 2019 in Wuhan, China was later named COVID-19. Due to its special pathogenicity, COVID-19 transmitted with high speed beyond borders and has significantly affected normal life. Currently, no specific drugs, treatment or vaccines are ava...
Autores principales: | Haq, Ehtisham Ul, Yu, Jifeng, Guo, Jiancheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470435/ https://www.ncbi.nlm.nih.gov/pubmed/32901214 http://dx.doi.org/10.1186/s40164-020-00180-4 |
Ejemplares similares
-
COVID-19 airborne transmission: a new frontier of infection
por: Banerjee, Indrajit, et al.
Publicado: (2021) -
Safeguarding the Frontier Covidians During the COVID-19 Pandemic:
Scuffles and Proposed Strategies
por: Vijay VR,, et al.
Publicado: (2020) -
Development of Vitiligo After COVID-19 Vaccination
por: Kara, Alper, et al.
Publicado: (2022) -
COVID-19 Vaccines: New Developments and the Road Ahead
por: Ita, Kevin, et al.
Publicado: (2021) -
The Role of Artificial Intelligence in the Development of COVID-19 Vaccine
por: Mohammad, Sattari, et al.
Publicado: (2023)